Clinical Trial Update: Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating esophageal reinforcement using a degradable Biologic Scaffold (ACell MatriStem) for esophageal adenocarcinoma; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma

Drugs mentioned

• ACell MatriStem Surgical Matrix

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-11-03